≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of liver and intrahepatic bile ducts

DOID Endpoint Browser

C3_LIVER_INTRAHEPATIC_BILE_DUCTS

liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C22
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — ANY

1 out of 7 registries used, show all original rules.

1116

4. Check minimum number of events

None

1116

5. Include endpoints

None

1116

6. Filter based on genotype QC (FinnGen only)

1074

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1074 234 840
Unadjusted period prevalence (%) 0.32 0.08 0.38
Median age at first event (years) 72.20 71.33 72.45

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1116
Matched controls
11160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
40.0
321.6
201
61
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
172.0
307.7
377
33
JN4CD
NOMESCO Finland
Very extensive body CT
46.0
307.7
201
53
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
211.2
307.7
378
27
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
581
*
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
537
*
A03FA01
ATC
metoclopramide; systemic, rectal
12.3
307.7
443
566
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
770
*
Z51.5
ICD-10 Finland
Palliative care
30.3
307.7
425
222
N02AA05
ATC
oxycodone; systemic
9.2
299.2
528
997
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
12.2
290.8
342
389
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
279.2
256
*
H02AB02
ATC
dexamethasone; systemic
37.9
271.0
171
53
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
264.4
243
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
29.3
253.2
174
70
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
40.2
228.3
141
40
R18
ICD-10 Finland
Ascites
28.8
228.2
157
63
198
Kela drug reimbursment
Sorafenib
+∞
215.8
200
*
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
214.7
199
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
201.3
187
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
35.7
199.2
127
40
WX302
NOMESCO Finland
Thoracal epidural anesthesy
20.7
188.1
148
82
JN4BD
NOMESCO Finland
Extensive body CT
11.0
185.9
218
240
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
26.7
173.9
122
51
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.6
166.6
158
125
A04AA01
ATC
ondansetron; systemic, rectal
22.7
165.7
124
61
JN4AD
NOMESCO Finland
Body CT examination
8.9
159.9
222
302
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
15.2
159.9
147
110
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
25.9
155.3
110
47
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
151.6
142
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.3
145.3
120
73
A04AA02
ATC
granisetron; systemic, transdermal
713.3
131.4
127
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.0
128.9
192
281
L01XE05
ATC
[U] sorafenib
+∞
128.7
121
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
125.2
294
677
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
114.4
447
1528
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
110.3
104
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1156.4
109.4
105
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
63.4
108.0
60
10
127
Kela drug reimbursment
Transplant complication
23.2
106.3
78
36
323
Kela drug reimbursment
Sorafenib
+∞
103.8
98
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
18.8
98.2
79
45
C03DA01
ATC
spironolactone; oral
4.1
96.8
345
1087
K83.1
ICD-10 Finland
Obstruction of bile duct
21.6
96.7
73
36
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
96.3
91
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
497.9
93.8
92
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
18.5
93.7
76
44
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
92.0
87
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
87.7
83
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
28.0
82.2
56
21
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
29.8
80.9
54
19
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
221.0
80.4
82
*
L04AA06
ATC
mycophenolic acid; systemic
15.2
78.2
70
49
K83.0
ICD-10 Finland
Cholangitis
12.5
75.4
76
65
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
32.0
75.1
49
16
WW500
NOMESCO Finland
Blood transfusion
9.9
74.9
89
97
L01BC06
ATC
capecitabine; oral
+∞
74.8
71
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
74.7
208
537
L04AD02
ATC
tacrolimus; systemic
26.7
73.6
51
20
Z94.4
ICD-10 Finland
Liver transplant status
135.8
71.9
76
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
71.3
465
2091
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.2
68.8
43
12
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
68.0
123
217
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
25.8
67.0
47
19
UJK02
NOMESCO Finland
ERCP
8.7
67.0
88
109
A05AA02
ATC
ursodeoxycholic acid; oral
15.8
65.2
57
38
JJC00
NOMESCO Finland
Allogenic transplantation of liver
233.6
64.9
66
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.4
64.8
113
192
L01EX02
ATC
sorafenib; oral
+∞
64.2
61
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
63.1
60
*
WZC30
NOMESCO Finland
Teaching
3.9
61.5
215
651
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
61.1
173
449
A06AH03
ATC
naloxegol; oral
27.2
61.1
42
16
WF002
NOMESCO Finland
Radical radiotherapy
87.7
59.6
66
8
WF049
NOMESCO Finland
Radiotherapy of metastasis
609.2
59.3
58
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
58.9
56
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
11.7
55.7
58
52
D77
ICPC
Malignant digestive neopl other/NOS
284.3
53.6
54
*
K76.9
ICD-10 Finland
Liver disease, unspecified
13.0
51.5
50
40
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
51.5
49
*
116
Kela drug reimbursment
Prostate cancer
+∞
51.5
49
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
20.2
50.4
39
20
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
50.4
498
2669
A06AD11
ATC
lactulose; oral
2.9
50.1
309
1308
L04AD01
ATC
ciclosporin; systemic
12.1
49.2
50
43
N02AX02
ATC
tramadol; systemic, rectal
2.5
48.7
569
3281
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
48.3
46
*
3019
Kela drug reimbursment
Lenvatinib
+∞
47.2
45
*
1508
Kela drug reimbursment
Lenvatinib
+∞
45.1
43
*
C03CA01
ATC
furosemide; systemic
2.4
44.9
581
3468
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
234.2
44.3
45
*
B01AB10
ATC
tinzaparin; parenteral
4.1
44.0
132
355
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
42.2
444
2403
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
422.6
41.4
41
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
14.0
40.9
38
28
A10BA02
ATC
metformin; oral
2.3
40.5
485
2766
L01EX08
ATC
lenvatinib; oral
+∞
39.8
38
*
176
Kela drug reimbursment
Regorafenib
+∞
39.8
38
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
39.4
208
799
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
7.4
39.3
58
82
N02AA01
ATC
morphine; systemic, rectal
8.7
38.8
50
60
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
74.3
38.2
43
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
37.7
36
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.4
37.3
42
42
B01AB05
ATC
enoxaparin; parenteral
2.4
37.2
370
1933
A10AE04
ATC
insulin glargine; parenteral
3.0
37.2
190
716
L03AA02
ATC
filgrastim; parenteral
103.7
37.0
40
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
36.9
298
1417
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
55.8
36.6
43
8
R50.9
ICD-10 Finland
Fever, unspecified
2.8
35.8
215
883
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.8
35.4
45
53
K92.0
ICD-10 Finland
Haematemesis
5.1
34.9
76
158
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
34.6
174
648
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
34.6
33
*
A10AB05
ATC
insulin aspart; parenteral
3.2
33.7
149
515
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
33.0
369
2008
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
32.4
31
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
56.1
32.4
38
7
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
31.5
285
1414
A07AA11
ATC
rifaximin; oral
54.6
31.5
37
7
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
31.4
30
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
31.4
30
*
ZX120
NOMESCO Finland
Intravenous
3.4
31.1
121
386
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
31.1
564
3679
A79
ICPC
Malignancy NOS
164.6
30.8
32
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
53.1
30.5
36
7
369
Kela drug reimbursment
Regorafenib
+∞
30.3
29
*
WX402
NOMESCO Finland
General anaesthesia
2.6
30.3
203
875
TK800
NOMESCO Finland
Hemodialysis
6.1
29.7
52
88
R4110
NOMESCO Finland
Physiotherapy
2.2
29.6
327
1759
A10BB12
ATC
glimepiride; oral
2.7
29.5
174
703
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
29.3
28
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.0
28.6
51
88
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
28.2
27
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
28.2
27
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
28.2
27
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
79.8
27.9
31
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
102.7
27.8
30
*
J01MA12
ATC
levofloxacin; systemic
2.3
27.7
263
1324
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.1
27.6
49
84
B01AB04
ATC
dalteparin; parenteral
4.0
27.5
80
209
T90
ICPC
Diabetes non-insulin dependent
2.1
27.4
361
2070
A04AA55
ATC
palonosetron, combinations; systemic
+∞
27.2
26
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
27.2
26
*
L02AE02
ATC
leuprorelin; implant, parenteral
77.1
26.9
30
*
UJF32
NOMESCO Finland
Coloscopy
2.1
26.7
315
1728
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
26.1
25
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
26.1
25
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
266.5
25.8
26
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
25.3
184
821
A02BC02
ATC
pantoprazole; systemic
1.9
24.1
723
5422
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.4
24.1
48
92
L02BB03
ATC
bicalutamide; oral
+∞
24.0
23
*
L01EX05
ATC
regorafenib; oral
+∞
24.0
23
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
24.0
23
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
24.0
23
*
L03AA13
ATC
pegfilgrastim; parenteral
88.7
23.7
26
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
88.7
23.7
26
*
JAH00
NOMESCO Finland
Laparotomy
4.9
23.3
52
110
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
23.0
22
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
234.6
22.7
23
*
TJA10
NOMESCO Finland
Laparocentesis
122.5
22.7
24
*
JJA20
NOMESCO Finland
Open biopsy of liver
122.5
22.7
24
*
SPAT1262
SPAT
Handing over of treatment supplies
2.1
22.6
251
1336
I81
ICD-10 Finland
Portal vein thrombosis
21.9
22.2
32
15
D13.4
ICD-10 Finland
Benign neoplasm: Liver
35.8
22.1
28
8
A41.8
ICD-10 Finland
Other specified sepsis
5.1
22.0
47
96
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.9
21
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
21.9
21
*
JJ5AT, ,
NOMESCO Finland
+∞
21.9
21
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
21.9
21
*
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
21.9
21
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
6.0
21.9
39
67
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
17.5
21.9
34
20
R4190
NOMESCO Finland
Nutritional therapy
5.4
21.7
43
82
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
224.2
21.7
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
21.5
254
1381
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
21.3
71
204
A10AE05
ATC
insulin detemir; parenteral
3.0
21.1
96
335
B18.2
ICD-10 Finland
Chronic viral hepatitis C
17.0
21.0
33
20
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.9
20
*
K92.1
ICD-10 Finland
Melaena
2.9
20.2
99
360
K72.1
ICD-10 Finland
Chronic hepatic failure
49.0
20.2
24
5
A10BH01
ATC
sitagliptin; oral
2.4
20.1
161
747
D97
ICPC
Liver disease NOS
23.9
20.0
28
12
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.3
19.7
40
78
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
35.0
18.9
24
7
A10AC01
ATC
insulin (human); parenteral
2.4
18.9
142
639
WW200, ,
SPAT
0.3
18.9
50
1584
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.8
18
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
18.8
18
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
18.8
18
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
18.8
18
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
18.8
18
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
18.8
18
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
18.3
64
190
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
18.3
59
166
JKA20
NOMESCO Finland
Cholecystectomy
3.7
18.2
58
162
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.0
18.1
230
1277
J01MA02
ATC
ciprofloxacin; systemic
1.8
18.0
457
3153
L01XE21
ATC
[U] regorafenib
+∞
17.8
17
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.8
17
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
17.8
17
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
17.7
174
876
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
182.8
17.6
18
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.3
17.3
35
68
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
16.9
91
348
XX4BW, ,
NOMESCO Finland
64.3
16.8
19
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
16.7
16
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
16.7
16
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
172.5
16.5
17
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
40.7
16.4
20
5
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.3
16.3
33
64
205
Kela drug reimbursment
Chronic hypertension
1.7
15.9
438
3064
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
15.7
15
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
15.7
15
*
160
Kela drug reimbursment
exenatide
4.3
15.6
40
95
JAH01
NOMESCO Finland
Laparoscopy
4.4
15.6
39
91
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
162.2
15.5
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
162.2
15.5
16
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.9
15.4
73
261
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
15.1
198
1105
A10BG03
ATC
pioglitazone; oral
3.4
15.1
54
163
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.1
15.1
41
102
SPAT1255
SPAT
Intravenous administration of medicine
2.5
15.0
96
400
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
14.9
40
1270
SPAT1109
SPAT
Analgesia with portable analgesic pump
18.7
14.7
22
12
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
21.4
14.7
21
10
N05CF01
ATC
zopiclone; oral
1.7
14.7
371
2524
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.2
14.6
30
59
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
14.6
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.6
14
*
RS220, ,
NOMESCO Finland
6.4
14.6
24
38
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
14.6
161
845
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
151.9
14.5
15
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
36.5
14.5
18
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
14.4
71
259
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
14.4
65
226
K70.0
ICD-10 Finland
Alcoholic fatty liver
6.5
14.1
23
36
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
14.1
174
949
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.1
14.1
25
21
Z2446
NOMESCO Finland
Social worker
2.7
13.9
76
293
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
24.1
13.8
19
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.8
325
2164
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.6
13.6
45
129
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
13.6
13
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
34.5
13.5
17
5
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
141.7
13.5
14
*
A98
ICPC
Health maint/preventive medicine
0.6
13.2
722
8376
C07AA05
ATC
propranolol; systemic
1.9
13.1
174
973
L04AX01
ATC
azathioprine; systemic
3.2
13.0
52
168
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
14.2
12.8
21
15
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.6
12.8
24
23
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
12.7
128
647
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
70.7
12.6
14
*
ZXE00
NOMESCO Finland
One hour or less
1.6
12.6
372
2615
L04AA10
ATC
[U] sirolimus
+∞
12.5
12
*
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
12.5
12
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
12.5
12
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
12.5
12
*
Z2221
NOMESCO Finland
Medical doctor
1.7
12.5
256
1633
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
131.4
12.5
13
*
A10BX04
ATC
[U] exenatide
5.9
12.3
22
38
D70.82
ICD-10 Finland
Drug-induced neutropenia
21.6
12.0
17
8
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
47.2
11.9
14
*
A10BB01
ATC
glibenclamide; oral
2.2
11.8
102
485
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
11.8
62
234
R10.0
ICD-10 Finland
Acute abdomen
3.5
11.7
40
117
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.9
11.7
54
190
C10AX09
ATC
ezetimibe; oral
0.4
11.5
51
1272
L01XE29
ATC
[U] lenvatinib
+∞
11.5
11
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
11.5
11
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
11.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.4
380
2737
A10BX07
ATC
[U] liraglutide
4.6
11.2
26
57
WVA20
NOMESCO Finland
Medicine administration
3.8
11.2
34
92
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.9
11.2
19
15
N06DX01
ATC
memantine; oral
0.3
11.1
26
899
Z3231
NOMESCO Finland
Registered nurse
1.7
11.1
270
1797
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.1
11.1
47
158
C10AA05
ATC
atorvastatin; oral
0.6
11.1
285
3995
K70.4
ICD-10 Finland
Alcoholic hepatic failure
14.0
11.0
18
13
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
10.8
27
63
WX892
NOMESCO Finland
Monitored bed care
2.2
10.8
98
476
C07AG02
ATC
carvedilol; oral
2.2
10.7
97
471
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.9
10.6
49
173
C10AA07
ATC
rosuvastatin; oral
0.5
10.6
148
2437
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.9
10.5
31
82
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
14.4
10.5
17
12
ZX070
NOMESCO Finland
Intensity modified radiotherapy
111.0
10.4
11
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
10.4
10
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
10.4
10
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
10.4
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
10.4
10
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
10.4
10
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
10.4
10
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
19.0
10.3
15
8
K72.9
ICD-10 Finland
Hepatic failure, unspecified
7.6
10.2
23
31
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.1
200
1257
XQ902
NOMESCO Finland
Other photography
10.2
10.0
19
19
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
10.0
59
237
ZX050
NOMESCO Finland
Stereotactic radiotherapy
40.4
10.0
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
10.0
47
168
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
9.9
79
1564
XW000
NOMESCO Finland
Bone marrow biopsy
2.9
9.8
45
158
HAB40
NOMESCO Finland
Wedge excision of mammary gland
26.3
9.8
13
5
K76.7
ICD-10 Finland
Hepatorenal syndrome
20.2
9.8
14
7
ZX108
NOMESCO Finland
Inhalation
9.6
9.8
19
20
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
9.6
93
463
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
9.6
181
2761
H02AB06
ATC
prednisolone; systemic
1.5
9.5
473
3680
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.5
66
1376
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
17.7
9.4
14
8
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
9.4
9
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
9.3
89
441
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.0
9.3
108
575
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
9.2
321
2313
HA1AA
NOMESCO Finland
X-ray mammography
4.3
9.1
23
54
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
11.6
9.1
16
14
P20
ICPC
Memory disturbance
0.5
9.0
71
1415
Y77
ICPC
Malignant neoplasm prostate
37.0
9.0
11
*
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
8.7
28
79
A10BG02
ATC
rosiglitazone; oral
3.4
8.7
30
89
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
8.6
60
261
ZXC40
NOMESCO Finland
Use of ultrasound
11.7
8.6
15
13
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
8.5
65
1312
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
27.7
8.5
11
*
K29.6
ICD-10 Finland
Other gastritis
4.3
8.4
21
49
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
90.7
8.4
9
*
H02AB04
ATC
methylprednisolone; systemic
1.7
8.4
149
906
C09BA02
ATC
enalapril and diuretics; systemic
1.9
8.4
118
669
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
8.4
97
516
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
4.9
8.4
18
37
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
8.4
64
290
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
8.3
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.3
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
8.3
178
1139
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
10.8
8.3
15
14
M04AA01
ATC
allopurinol; systemic
1.6
8.3
201
1329
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
8.3
68
318
A10BD07
ATC
metformin and sitagliptin; systemic
2.3
8.2
62
279
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
8.2
115
651
K70.1
ICD-10 Finland
Alcoholic hepatitis
6.5
8.2
20
31
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
33.6
8.1
10
*
ZXD05
NOMESCO Finland
Urgent procedure
1.5
8.1
305
2229
SPAT1088
SPAT
Blood transfusion
10.1
8.0
15
15
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
8.0
23
713
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.0
8.0
34
115
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.3
8.0
18
25
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
7.9
212
3005
K75.0
ICD-10 Finland
Abscess of liver
13.1
7.9
13
10
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.9
122
713
UJD02
NOMESCO Finland
Gastroscopy
2.2
7.9
62
285
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.6
7.7
45
180
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
45.3
7.7
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.3
7.7
9
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
7.7
56
249
A10BB07
ATC
glipizide; oral
2.9
7.6
34
118
XF612
NOMESCO Finland
Measurement of central venous pressure
25.2
7.6
10
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
7.5
53
232
B01AF01
ATC
rivaroxaban; oral
0.4
7.5
43
967
I85
ICD-10 Finland
Oesophageal varices
80.6
7.4
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
80.6
7.4
8
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.8
7.4
37
137
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.4
150
947
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
YJ3VG
NOMESCO Finland
MRI examination of abdomen with high intesity magnet for dose design of radiotherapy
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
SPAT1122
SPAT
Ascites puncture
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
7.3
7
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
9.4
7.3
14
15
A10BD03
ATC
metformin and rosiglitazone; systemic
3.0
7.3
31
105
EB1VA, ,
NOMESCO Finland
0.3
7.2
15
556
WX004
NOMESCO Finland
Patient-controlled sedation
15.9
7.2
11
7
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
7.2
330
2497
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
30.2
7.2
9
*
J01FF01
ATC
clindamycin; systemic
1.5
7.2
254
1826
A10BH05
ATC
linagliptin; oral
2.0
7.0
75
388
V03AE01
ATC
polystyrene sulfonate; oral
3.5
7.0
23
66
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.9
7.0
20
52
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.0
75
389
TDA90, ,
SPAT
0.2
7.0
7
338
K51.5
ICD-10 Finland
Left sided colitis
3.0
7.0
29
97
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.9
72
369
WX882
NOMESCO Finland
High dependency care
2.8
6.9
34
125
K76.89
ICD-10 Finland
Other specified diseases of liver
13.9
6.9
11
8
D05AX52
ATC
calcipotriol, combinations; topical
2.2
6.9
54
248
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
6.8
29
98
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
8.3
6.8
14
17
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.1
6.8
18
44
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.7
6.8
16
24
D69.5
ICD-10 Finland
Secondary thrombocytopenia
40.3
6.8
8
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
40.3
6.8
8
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
6.8
43
180
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
6.8
85
1463
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.7
80
430
WPB10
NOMESCO Finland
Making a convalescent care decision
22.7
6.7
9
*
N06DA02
ATC
donepezil; oral
0.4
6.7
25
678
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.7
269
1982
B02AA02
ATC
tranexamic acid; systemic
1.9
6.7
81
439
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
6.6
41
170
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.9
6.6
30
106
C10AC01
ATC
colestyramine; oral
3.0
6.5
27
90
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
6.5
62
308
J94.8
ICD-10 Finland
Other specified pleural conditions
3.2
6.5
25
80
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.5
6.5
69
1248
L02BA01
ATC
tamoxifen; oral
70.2
6.4
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.2
6.4
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.2
6.4
7
*
L04AA18
ATC
[U] everolimus
70.2
6.4
7
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
70.2
6.4
7
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
70.2
6.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
70.2
6.4
7
*
ZZR00
NOMESCO Finland
Flap of skin
7.4
6.4
14
19
B01AF02
ATC
apixaban; oral
0.5
6.4
54
1055
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
6.4
43
185
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
6.4
53
250
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.3
100
588
162
Kela drug reimbursment
liraglutide
3.6
6.3
20
56
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.6
6.3
17
31
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
11.1
6.3
11
10
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.3
6.3
23
71
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
18.1
6.3
9
5
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
8010/3-C22.1
ICD-O-3
Carcinoma, NOS, of intrahepatic bile duct
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
8180/3-C22.0
ICD-O-3
Combined hepatocellular carcinoma and cholangiocarcinoma of liver
+∞
6.3
6
*
L01BC04
ATC
carmofur; oral
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
L04AH02
ATC
everolimus; oral
+∞
6.3
6
*
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
26.8
6.2
8
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
26.8
6.2
8
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
26.8
6.2
8
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
6.2
63
321
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.0
6.2
17
43
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.8
6.2
16
28
N05AX08
ATC
risperidone; systemic
0.4
6.1
32
747
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
6.0
77
424

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
273
187
19.00
317.47
5.0
2.2
44.45
34.96
umol/l
3.49
258
170
230
81
35.51
307.65
4.0
1.6
400.42
36.97
u/ml
2.41
218
71
263
25
137.33
307.65
1.8
1.4
—
—
—
0
0
288
191
19.98
307.65
1.7
1.3
—
—
—
0
0
576
404
28.40
307.65
4.5
1.3
25.54
2.92
ug/l
1.24
505
302
458
607
12.10
307.65
5.9
2.0
0.17
0.19
g/l
6.00
434
539
401
141
43.83
307.65
4.4
1.8
819.82
50.01
u/ml
2.67
361
108
227
175
16.03
245.45
1.5
1.1
58.00
82.50
titre
0.47
15
12
428
787
8.20
242.87
12.0
2.3
22.43
9.89
umol/l
5.11
405
686
169
82
24.11
228.41
1.3
1.0
1.66
1.58
g/l
0.76
161
74
97
10
106.14
188.09
4.4
3.3
—
—
—
0
0
306
534
7.52
177.84
1.7
1.4
—
—
—
0
0
297
518
7.45
172.36
1.7
1.5
—
—
—
0
0
353
784
6.12
159.61
12.8
6.2
8.72
11.38
mmol/l
8.24
339
731
77
20
41.28
126.55
4.6
1.8
—
—
—
0
0
73
23
33.89
113.64
2.4
1.9
754.06
409.18
e6/l
0.85
53
17
708
3384
3.99
109.86
16.3
3.7
31.23
34.90
g/l
44.12
675
3066
488
1841
3.93
107.33
16.2
3.7
74.96
80.55
%
5.16
472
1785
547
2239
3.83
106.34
13.4
2.6
66.80
37.90
u/l
5.81
534
2119
745
3797
3.89
102.39
27.2
3.8
26.22
13.09
umol/l
12.25
723
3550
64
19
35.67
101.22
2.2
1.9
—
—
—
0
0
64
20
33.89
99.71
2.3
1.9
1003.33
93056.83
e6/l
0.52
39
12
60
16
39.57
97.64
1.3
3.8
—
—
—
0
0
59
18
34.55
92.48
1.0
1.0
—
—
—
0
0
58
17
35.93
91.95
1.1
1.1
—
—
—
0
0
161
283
6.48
90.02
1.3
1.4
—
—
—
0
0
350
1178
3.87
88.50
6.3
2.7
0.77
0.82
mmol/l
11.92
337
1071
55
17
33.98
85.81
2.2
2.1
—
—
—
0
0
70
41
18.15
85.70
2.3
2.2
—
—
—
0
0
70
41
18.15
85.70
1.2
1.1
—
—
—
0
0
534
2396
3.36
85.45
5.9
2.2
56.08
62.07
u/l
1.29
513
2195
180
371
5.59
85.00
1.6
1.3
1.45
1.16
g/l
1.60
157
336
193
456
4.91
77.55
2.1
1.9
13.41
11.06
g/l
5.52
172
413
230
626
4.37
77.29
4.8
2.2
31.44
39.44
u/l
0.54
205
510
119
183
7.16
75.30
8.2
3.4
1.72
1.70
mg/l
0.10
108
160
82
88
9.98
69.71
1.3
1.4
114.00
109.88
u/ml
—
6
10
71
62
12.16
69.48
1.3
1.3
84.62
227.00
titre
—
13
10
481
2236
3.02
69.06
4.2
2.2
—
—
—
0
0
313
1139
3.43
68.21
2.8
2.6
25.89
22.50
%
2.38
287
954
192
511
4.33
65.88
1.3
1.1
—
—
—
0
0
85
107
8.52
63.82
1.4
1.4
—
—
—
0
0
715
4266
2.88
62.11
23.7
20.7
1.35
1.44
inr
1.78
196
1189
315
1216
3.22
61.59
2.7
2.5
2.25
2.23
g/l
0.13
294
1113
80
98
8.72
61.37
1.4
1.3
377.93
230.57
u/ml
2.79
56
53
43
18
24.81
60.43
1.8
1.2
9.14
12.80
g/l
0.83
31
11
488
2468
2.74
57.34
6.4
4.2
—
—
—
0
0
383
1726
2.86
56.05
4.3
2.2
—
—
—
0
0
45
27
17.32
54.17
1.2
1.1
—
—
—
0
0
318
1320
2.97
53.90
2.8
2.5
13.17
12.50
umol/l
0.79
301
1202
579
3329
2.54
50.43
5.0
2.3
—
—
—
0
0
83
138
6.42
48.42
1.4
1.2
—
—
—
0
0
78
128
6.48
46.07
2.2
1.2
—
—
—
0
0
46
43
11.11
42.86
1.1
1.1
—
—
—
0
0
45
41
11.39
42.64
1.1
1.0
—
—
—
0
0
639
4058
2.34
41.77
19.0
5.8
4.31
4.52
e9/l
1.16
577
3471
253
1084
2.73
39.04
9.2
5.1
1.06
1.02
mmol/l
1.14
235
978
386
2080
2.31
35.90
2.6
1.6
—
—
—
0
0
61
101
6.33
35.64
1.1
1.2
—
—
—
0
0
44
54
8.44
33.53
1.0
1.0
278.84
293.49
mg/l
0.42
37
49
192
768
2.81
33.44
9.8
7.4
—
—
—
0
0
608
4015
2.13
33.14
10.7
5.5
1.19
1.21
mmol/l
5.32
518
3389
252
1162
2.51
32.93
2.7
2.0
—
—
—
0
0
665
4560
2.13
32.62
13.1
3.0
224.42
53.40
u/l
41.79
636
4121
407
2328
2.18
31.98
6.2
3.2
7.40
7.40
ph
0.07
92
408
559
3677
2.04
29.64
9.8
5.4
1.19
1.20
mmol/l
4.74
535
3262
209
926
2.55
29.45
5.5
3.2
1.15
2.04
mmol/l
2.85
158
755
208
926
2.53
28.98
5.4
3.2
5.57
5.85
kpa
2.91
202
883
198
864
2.57
28.76
1.5
1.3
364.80
492.73
titre
0.86
50
198
181
778
2.58
27.02
8.0
6.6
1.80
1.53
mmol/l
1.35
175
754
50
93
5.58
25.90
1.1
1.0
—
—
—
0
0
126
463
2.94
25.39
10.6
9.5
—
—
—
0
0
672
4872
1.95
25.37
12.0
4.6
7.47
6.94
mmol/l
5.65
649
4563
160
688
2.55
23.71
1.5
1.5
—
—
—
0
0
306
1729
2.06
23.58
14.4
4.5
—
—
—
0
0
215
1058
2.28
23.58
8.6
6.9
12.40
11.08
kpa
4.03
202
999
215
1058
2.28
23.58
8.6
6.9
4.97
5.10
kpa
1.28
202
1002
214
1060
2.26
23.06
8.6
6.9
0.22
1.38
mmol/l
3.68
171
821
47
95
5.12
22.22
1.1
1.0
—
—
—
0
0
760
5885
1.91
21.91
29.3
5.2
171.84
77.69
u/l
51.89
733
5410
103
367
2.99
21.86
2.1
1.7
1.27
2.11
ug/l
1.02
97
317
196
959
2.27
21.66
9.1
7.1
96.26
94.75
%
2.62
187
917
198
977
2.25
21.42
1.4
1.2
—
—
—
0
0
500
3433
1.83
20.89
9.1
5.6
9.42
8.99
%
1.80
470
3156
506
3490
1.82
20.80
8.9
5.4
22.89
25.66
%
6.05
476
3220
180
866
2.29
20.64
9.4
7.3
117.01
122.76
g/l
2.91
172
847
287
1660
1.98
20.31
3.9
2.8
565.87
557.26
mosm/kgh2o
0.29
265
1402
264
1488
2.01
20.08
7.5
2.2
2.50
2.44
mmol/l
10.87
246
1254
355
2216
1.88
19.93
4.3
3.0
1.02
0.43
e6/l
2.02
293
1698
384
2472
1.84
19.46
4.4
3.1
65.38
87.71
e6/l
0.29
318
1920
492
3418
1.79
19.32
8.9
5.3
2.62
3.00
%
3.07
463
3141
27
12
23.02
19.12
1.1
1.1
—
—
—
0
0
477
3313
1.77
18.52
9.0
5.3
0.60
0.64
%
0.85
446
3046
213
1141
2.07
18.49
1.7
1.2
4.17
2.87
g/l
7.58
168
640
381
2479
1.82
18.45
7.5
2.0
2.31
2.34
mmol/l
2.78
356
2031
230
1287
1.99
17.62
3.5
2.8
1.27
1.49
e6/l
0.40
148
718
490
3465
1.74
17.60
8.6
5.3
61.36
58.92
%
3.95
460
3200
335
2134
1.81
17.17
4.3
3.0
—
—
—
0
0
516
3736
1.71
16.75
8.8
5.2
1.45
1.79
e9/l
21.66
453
3241
507
3674
1.70
16.26
8.8
5.0
0.04
0.04
e9/l
2.43
435
3118
474
3374
1.70
16.24
9.9
5.4
—
—
—
0
0
504
3659
1.69
15.96
8.8
5.0
0.65
0.63
e9/l
0.58
435
3106
516
3785
1.68
15.59
9.4
5.2
0.18
0.21
e9/l
3.28
448
3264
283
1761
1.81
15.43
1.6
1.3
—
—
—
0
0
38
91
4.29
14.68
3.8
2.9
1.85
1.21
%
0.43
33
75
230
1362
1.87
14.63
3.4
2.6
0.84
1.04
e6/l
0.62
149
788
403
2814
1.68
14.40
5.0
3.5
72.96
107.42
e6/l
0.64
327
2048
42
116
3.72
13.39
5.8
6.3
11.20
12.17
mg/l
0.42
36
108
663
7844
0.62
13.12
5.9
5.4
2.39
2.53
mmol/l
3.61
581
7104
637
7603
0.62
13.06
5.7
4.8
4.14
4.34
mmol/l
4.75
569
6924
26
28
9.48
13.01
3.4
2.2
47211.54
40289.29
ug/l
1.23
26
28
20
12
16.95
13.01
1.2
1.0
—
—
—
0
0
126
630
2.13
12.91
5.6
3.1
1.21
1.22
mmol/l
1.23
116
533
145
767
2.02
12.78
4.9
2.8
4.79
4.45
kpa
1.13
140
725
268
1725
1.73
12.70
3.7
2.4
5.35
4.48
e6/l
0.61
255
1547
263
3841
0.59
12.52
3.3
3.8
23.36
24.32
%
0.39
109
1910
653
7712
0.63
12.24
5.4
5.0
6.63
6.16
mmol/l
10.40
572
6896
635
7524
0.64
11.79
5.5
4.8
1.23
1.37
mmol/l
14.22
558
6796
634
5117
1.55
11.48
4.9
4.4
1143.79
3096.32
e6/l
0.68
14
104
26
57
4.65
11.22
1.8
1.5
—
—
—
0
0
318
2202
1.62
11.20
2.9
2.3
3.78
2.95
mg/l
5.66
272
1823
108
540
2.11
11.05
5.4
3.6
1.42
0.72
%
1.58
66
164
54
197
2.83
11.00
5.6
4.7
1.84
2.57
mmol/l
1.76
33
132
58
229
2.62
10.17
5.8
4.5
7.43
7.42
ph
0.79
52
206
168
2637
0.57
10.00
2.4
2.7
0.77
0.74
ug/l
0.18
106
1855
50
186
2.77
9.84
1.2
1.5
253.81
283.99
ug/g
0.40
27
112
33
96
3.51
9.80
1.8
1.7
0.81
1.10
g/l
0.44
21
76
51
194
2.71
9.63
4.1
4.1
—
—
—
0
0
622
7284
0.67
9.55
5.1
4.3
1.43
1.28
mmol/l
3.70
549
6520
35
112
3.19
8.98
3.9
3.1
54.43
59.46
%
1.02
35
112
125
2053
0.56
8.59
2.2
1.6
1.72
1.35
mmol/l
3.32
114
1687
93
484
2.01
8.55
5.2
3.6
0.78
0.58
%
0.58
54
141
112
622
1.89
8.51
3.2
1.8
423.87
359.15
nmol/l
2.22
105
550
392
2988
1.48
8.49
3.7
2.8
230.29
153.60
ug/l
3.29
359
2702
370
4723
0.68
8.42
3.8
3.9
2.12
2.13
ug/l
0.02
296
4193
114
648
1.85
8.06
6.0
4.6
—
—
—
0
0
96
516
1.94
8.05
5.9
3.7
0.09
0.05
%
0.40
55
139
21
51
4.18
8.02
1.7
1.1
—
—
—
0
0
63
290
2.24
7.95
6.9
5.6
2.01
1.35
mmol/l
1.01
51
262
117
677
1.81
7.81
1.6
1.3
—
—
—
0
0
316
2342
1.49
7.74
3.2
3.2
—
—
—
0
0
651
7446
0.70
7.68
9.4
6.6
44.23
41.30
mmol/mol
7.61
585
6807
123
729
1.77
7.58
1.9
1.6
65.70
66.59
g/l
0.50
107
643
109
623
1.83
7.58
8.3
6.8
23.15
24.59
mmol/l
3.21
100
595
27
749
0.34
7.55
1.4
1.5
—
—
—
0
0
40
154
2.66
7.43
1.3
1.3
56.64
64.36
mmol/l
0.39
22
121
32
110
2.97
7.32
3.8
2.8
3.91
4.77
e9/l
0.88
32
110
151
2274
0.61
7.27
4.3
3.3
—
—
—
0
0
135
844
1.68
6.87
1.9
1.4
—
—
—
0
0
88
486
1.88
6.82
5.8
3.8
0.04
0.02
%
0.37
45
112
608
6977
0.72
6.79
4.6
4.2
2.62
2.22
mu/l
1.09
535
6202
74
388
1.97
6.69
6.4
4.3
0.90
0.88
%
0.20
65
368
216
1525
1.52
6.58
2.1
1.7
2.83
1.31
mg/l
3.26
180
1193
296
2229
1.45
6.52
4.3
2.6
5503.53
7978.96
umol/l
0.35
265
1885
167
1122
1.57
6.36
2.9
2.0
2.11
1.75
%
2.28
153
963
31
115
2.74
6.22
2.2
1.8
—
—
—
0
0
365
2879
1.40
6.14
3.5
3.1
7.12
7.83
mmol/l
2.96
296
2405
73
394
1.91
6.09
6.6
4.2
1.75
1.75
%
0.01
66
374
378
3005
1.39
6.05
4.1
3.8
13.21
7.83
mg/mmol
1.43
272
1993
624
5396
1.35
5.77
5.1
4.1
—
—
—
0
0
780
8521
0.72
5.73
57.4
21.3
122.97
136.41
g/l
74.24
751
8291
66
352
1.93
5.71
1.2
1.3
—
—
—
0
0
780
8520
0.72
5.71
56.6
21.1
30.32
30.58
pg
2.53
751
8292
780
8520
0.72
5.71
56.9
21.2
4.13
4.49
e12/l
46.85
743
8138
780
8518
0.72
5.68
56.7
21.1
91.44
91.76
fl
0.86
752
8289
780
8517
0.72
5.66
56.9
21.2
204.54
234.09
e9/l
16.19
746
8183
780
8517
0.72
5.66
56.9
21.2
7.11
6.92
e9/l
1.20
743
8140
780
8514
0.72
5.62
57.5
21.4
36.85
40.16
%
33.73
694
7717
44
204
2.20
5.53
8.6
6.1
105.49
105.65
mmol/l
0.09
37
186
44
204
2.20
5.53
8.6
6.1
12.86
11.39
mmol/l
1.09
37
186
5
0
+∞
5.21
15.6
0.0
8.88
—
ug/l
—
5
0
5
0
+∞
5.21
8.8
0.0
0.12
—
umol/l
—
5
0
467
5463
0.75
5.16
4.1
3.4
14.70
15.08
pmol/l
2.47
414
4845
55
293
1.92
4.82
3.6
2.3
0.18
0.25
g/l
0.89
38
95
141
978
1.51
4.63
1.7
1.8
—
—
—
0
0
24
92
2.64
4.58
2.0
1.5
—
—
—
0
0
135
932
1.51
4.53
2.8
3.2
234.44
277.65
ng/l
0.65
124
865
39
188
2.11
4.50
3.3
2.5
14.57
16.41
%
1.34
17
102
28
117
2.43
4.50
2.4
2.3
—
—
—
0
0
10
16
6.30
4.30
1.0
2.3
—
—
—
0
0
64
1049
0.59
4.22
1.1
1.3
61.89
38.10
iu/ml
0.21
22
315
28
121
2.35
4.20
2.4
2.3
107.04
105.25
mmol/l
1.46
28
121
28
121
2.35
4.20
2.4
2.3
4.34
4.12
mmol/l
1.11
28
121
391
3265
1.30
4.18
22.1
8.6
0.00
0.00
e9/l
0.59
312
2635
346
2842
1.32
4.17
3.4
3.2
525.58
164.14
mg/l
0.74
256
1908
60
346
1.78
4.14
4.7
4.3
2.16
1.45
mmol/l
1.23
60
340
45
237
1.94
4.11
3.5
3.6
—
—
—
0
0
6
225
0.26
3.94
1.0
1.1
—
—
—
0
0
40
206
1.98
3.91
1.8
1.4
—
—
—
0
0
68
415
1.68
3.86
1.6
1.6
1.20
1.44
g/l
1.45
56
347
25
107
2.37
3.85
1.8
1.5
25927.71
90872.09
e6/l
0.60
17
66
62
994
0.60
3.75
1.1
1.2
22.82
14.24
u/ml
0.27
22
363
26
115
2.29
3.73
1.9
1.5
707.29
1426.81
e6/l
1.55
21
81
118
828
1.48
3.68
3.1
2.0
80.28
67.05
e9/l
1.98
93
639
8
12
6.70
3.67
1.3
3.7
—
—
—
0
0
14
40
3.53
3.61
2.1
3.2
—
—
—
0
0
17
63
2.72
3.50
3.0
3.4
—
—
—
0
0
764
8196
0.78
3.40
33.8
9.1
44.02
25.96
u/l
38.28
742
7780
63
392
1.64
3.35
6.0
4.9
—
—
—
0
0
22
95
2.34
3.35
2.0
1.5
—
—
—
0
0
14
48
2.94
3.30
1.1
1.2
—
—
—
0
0
23
102
2.28
3.30
2.0
1.5
—
—
—
0
0
18
71
2.56
3.30
1.2
1.1
—
—
—
0
0
0
83
0.00
3.13
0.0
1.0
—
324.64
—
0
55
776
8282
0.79
3.10
46.2
18.3
4.05
4.02
mmol/l
1.41
748
7996
27
132
2.07
3.08
1.3
1.4
8.18
7.17
u/l
0.28
18
108
13
41
3.20
3.06
1.7
2.2
1.18
1.10
e9/l
0.11
13
35
8
16
5.03
3.05
2.4
1.4
—
—
—
0
0
24
113
2.15
3.02
1.5
1.3
—
—
—
0
0
14
51
2.77
2.99
1.1
1.1
—
—
—
0
0
8
17
4.73
2.92
1.8
1.5
—
—
—
0
0
11
32
3.46
2.90
2.4
2.3
31.85
43.93
%
1.31
11
32
776
8261
0.80
2.88
46.0
18.2
137.74
139.74
mmol/l
51.94
751
7987
55
345
1.63
2.87
1.5
1.5
3.28
34.64
u/ml
—
5
8
87
607
1.47
2.84
3.7
3.7
92.03
96.00
ng/l
0.21
79
509
34
187
1.84
2.81
3.0
2.8
—
—
—
0
0
227
1857
1.28
2.71
3.9
4.2
369.75
474.58
ng/l
0.27
197
1618
405
3543
1.22
2.66
4.3
4.2
40.03
77.46
ng/l
1.71
332
2739
17
73
2.35
2.66
2.6
3.3
—
—
—
0
0
46
283
1.65
2.61
2.0
1.4
38.98
36.21
mg/l
0.24
31
231
46
284
1.65
2.58
2.0
1.4
59.85
47.42
mg/l
0.70
31
231
84
597
1.44
2.51
4.4
3.7
—
—
—
0
0
10
256
0.39
2.50
1.5
1.5
—
—
—
0
0
19
90
2.13
2.39
1.6
2.4
886.20
624.83
ml
—
10
58
9
27
3.35
2.39
1.7
1.7
47.84
57.59
ug/l
—
9
27
13
52
2.52
2.36
1.8
1.6
10.61
14.64
umol/l
1.63
13
44
69
479
1.47
2.35
3.7
2.5
0.55
0.30
e6/l
0.45
69
468
40
245
1.66
2.34
4.6
4.3
—
—
—
0
0
9
219
0.41
2.31
1.0
1.1
—
—
—
0
0
45
286
1.60
2.28
2.0
2.2
126.91
109.24
ug/min
0.10
27
174
7
18
3.91
2.25
1.3
1.0
—
—
—
0
0
87
637
1.40
2.23
1.8
1.4
—
—
—
0
0
15
310
0.48
2.22
22.7
10.6
—
—
—
0
0
106
803
1.35
2.21
3.7
3.4
—
—
—
0
0
5
9
5.57
2.21
1.2
1.2
—
—
—
0
0
8
24
3.35
2.18
1.0
1.1
1158.50
1588.13
miu/ml
—
8
24
8
24
3.35
2.18
1.3
1.0
—
—
—
0
0
34
204
1.69
2.16
3.5
2.8
—
—
—
0
0
38
590
0.63
2.09
1.4
1.4
—
—
—
0
0
16
312
0.51
2.02
1.2
1.4
—
—
—
0
0
753
7947
0.84
2.01
36.7
14.2
—
—
—
0
0
7
21
3.35
1.96
1.1
1.0
—
—
—
0
0
22
120
1.85
1.93
6.8
4.0
—
—
—
0
0
11
45
2.46
1.93
1.1
1.4
—
—
—
0
0
80
596
1.37
1.89
3.8
3.6
7.42
7.40
ph
—
10
72
184
2189
0.81
1.88
1.7
1.6
16.70
19.72
nmol/l
2.75
164
1833
6
17
3.54
1.84
1.3
1.4
—
—
—
0
0
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
591
6336
0.86
1.81
51.0
19.5
331.17
332.74
g/l
3.55
579
6257
6
18
3.35
1.75
1.2
1.4
—
—
—
0
0
26
157
1.67
1.66
1.3
1.2
—
—
—
0
0
225
1940
1.20
1.65
4.4
3.3
—
—
—
0
0
79
606
1.33
1.58
3.9
3.6
4.78
5.20
kpa
5.06
72
569
87
677
1.31
1.57
3.0
2.4
249.29
163.67
ug/g
0.91
67
529
224
1939
1.19
1.57
1.8
1.8
1189.11
1147.62
nmol/l
0.26
172
1453
49
349
1.42
1.54
1.6
1.4
13.07
10.65
g/l
1.48
39
299
15
79
1.91
1.50
2.3
1.8
1.57
2.41
g/24h
—
10
39
14
72
1.96
1.49
1.4
1.2
2.31
1.57
nmol/l
1.01
14
61
59
438
1.37
1.47
2.4
2.4
—
—
—
0
0
15
80
1.89
1.45
1.4
1.2
2.22
7.03
u/ml
—
9
36
6
22
2.74
1.43
1.5
1.4
—
—
—
0
0
12
60
2.01
1.38
1.6
1.2
—
—
—
0
0
18
104
1.74
1.37
2.4
2.9
—
—
—
0
0
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
16
270
0.59
1.32
1.3
1.3
—
—
—
0
0
611
6456
0.88
1.31
52.4
16.9
15.63
15.30
%
1.31
598
6292
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
12
62
1.95
1.28
1.3
1.2
—
—
—
0
0
41
296
1.40
1.24
1.7
1.3
35.41
37.10
g/l
0.90
33
247
5
19
2.64
1.21
1.6
2.1
—
—
—
0
0
328
2985
1.14
1.20
2.8
3.2
1392.27
1881.71
ng/l
0.91
282
2577
13
224
0.58
1.18
1.5
1.5
20165.63
19666.88
e6/l
—
8
165
41
303
1.37
1.10
3.7
3.1
4.04
4.41
pmol/l
1.48
35
258
5
21
2.39
1.09
6.2
2.6
—
—
—
0
0
7
32
2.19
1.08
2.0
1.6
0.12
0.20
e9/l
—
7
27
15
89
1.69
1.08
1.2
1.1
—
—
—
0
0
7
33
2.13
1.05
2.0
1.6
300.29
399.96
e6/l
—
7
27
284
2584
1.13
1.04
4.4
4.3
—
—
—
0
0
43
324
1.34
1.04
2.7
1.9
—
—
—
0
0
9
46
1.96
1.03
1.0
1.2
—
—
—
0
0
0
30
0.00
0.97
0.0
1.5
—
0.25
—
0
30
0
32
0.00
0.95
0.0
1.1
—
35.89
—
0
14
9
156
0.57
0.88
1.0
1.4
—
—
—
0
0
10
56
1.79
0.88
1.9
1.3
0.65
1.28
promille
—
10
45
12
72
1.67
0.85
4.3
2.2
10.33
10.81
%
0.16
12
72
74
617
1.21
0.84
1.4
1.5
—
—
—
0
0
55
448
1.24
0.78
4.5
3.5
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
229
2097
1.12
0.76
4.9
3.8
0.00
0.01
estimate
0.50
67
595
9
142
0.63
0.70
1.1
1.1
—
—
—
0
0
38
469
0.80
0.64
1.2
1.1
—
—
—
0
0
13
87
1.50
0.63
1.3
1.3
—
—
nmol/l
—
0
0
217
2006
1.10
0.62
1.8
1.7
436.24
30018833.91
pmol/l
1.71
175
1629
314
2955
1.09
0.61
2.9
2.2
74.41
76.97
nmol/l
0.78
284
2529
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
144
1306
1.12
0.59
1.2
1.2
1.64
1.69
u/ml
0.03
23
356
52
437
1.20
0.59
4.1
3.7
—
—
—
0
0
27
211
1.29
0.57
1.2
1.2
—
—
—
0
0
16
217
0.73
0.55
1.3
1.3
—
—
—
0
0
10
148
0.67
0.55
1.0
1.4
—
—
—
0
0
11
74
1.49
0.53
1.9
1.3
—
—
—
0
0
20
154
1.30
0.48
5.0
2.3
65.28
64.22
%
0.09
20
154
8
119
0.67
0.46
1.6
1.1
—
—
—
0
0
105
955
1.11
0.44
2.3
2.5
6.75
7.44
ug/l
0.15
88
822
395
3797
1.06
0.43
4.5
3.5
0.01
0.01
estimate
0.18
90
695
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
7
102
0.68
0.39
1.4
1.8
—
—
—
0
0
53
466
1.14
0.39
2.9
3.3
9.39
6.02
e9/l
0.32
47
340
26
215
1.21
0.38
2.6
2.1
113.21
133.39
g/l
3.35
19
157
5
37
1.35
0.37
1.2
1.5
1.00
3.33
u/field
—
5
24
16
202
0.79
0.37
1.8
2.6
—
—
—
0
0
12
90
1.34
0.36
1.2
1.3
—
—
—
0
0
6
43
1.40
0.35
1.3
1.8
—
—
—
0
0
68
751
0.90
0.34
3.6
2.9
—
—
—
0
0
6
44
1.37
0.34
1.0
1.1
110.33
138.87
nmol/l
—
6
44
12
154
0.78
0.32
1.8
2.5
—
—
—
0
0
7
52
1.35
0.31
2.0
1.5
9.97
10.63
mmol/l
—
7
52
395
3831
1.05
0.31
4.5
3.6
0.00
0.00
estimate
0.50
75
616
25
293
0.85
0.30
1.8
1.8
—
—
—
0
0
388
3767
1.05
0.29
6.0
4.8
0.00
0.00
estimate
-0.00
80
638
316
3056
1.05
0.28
4.3
3.3
5.61
5.89
ph
—
9
139
27
311
0.86
0.27
1.2
1.2
12.67
138.80
iu/ml
—
6
119
11
86
1.28
0.26
1.1
1.2
330.33
338.88
nmol/l
—
6
72
5
74
0.67
0.26
1.8
2.1
1.58
3.26
ug/l
—
5
69
9
72
1.25
0.25
1.8
1.2
—
—
—
0
0
364
3742
0.96
0.25
2.0
2.1
88.18
91.61
pmol/l
0.65
185
1993
9
74
1.22
0.25
1.2
1.3
—
—
—
0
0
9
75
1.20
0.25
1.6
1.3
—
—
—
0
0
10
78
1.28
0.24
1.4
1.1
—
—
—
0
0
6
81
0.74
0.24
2.3
1.2
—
—
—
0
0
6
81
0.74
0.24
2.3
1.2
—
—
—
0
0
6
83
0.72
0.24
2.3
1.2
—
—
—
0
0
6
83
0.72
0.24
2.3
1.2
—
—
—
0
0
6
84
0.71
0.24
1.5
1.3
15988.33
288443.07
e6/l
—
6
58
23
199
1.16
0.23
1.4
1.2
—
—
—
0
0
14
167
0.84
0.21
1.6
2.1
215.00
219.33
pmol/l
0.08
14
154
5
42
1.19
0.21
1.8
3.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
15.93
—
0
11
0
11
0.00
0.21
0.0
1.0
—
7.55
—
0
6
0
10
0.00
0.21
0.0
1.4
—
382.90
—
0
10
12
98
1.23
0.21
1.3
1.3
1.94
0.63
nmol/l
0.50
12
92
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
6.8
—
6.52
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
2.4
1.5
—
—
—
0
0
5
69
0.72
0.17
18.0
14.2
—
—
—
0
0
6
80
0.75
0.15
2.3
1.2
—
—
—
0
0
40
429
0.93
0.14
1.2
1.3
—
—
—
0
0
23
252
0.91
0.12
1.1
1.1
—
216.83
—
0
6
13
115
1.13
0.10
2.2
2.6
—
—
—
0
0
569
5742
0.98
0.10
5.4
3.9
23.73
12.88
mm/h
21.22
514
5218
562
5665
0.98
0.09
4.8
4.3
—
—
—
0
0
6
58
1.03
0.08
1.7
1.6
—
—
—
0
0
58
558
1.04
0.08
3.3
3.0
—
—
—
0
0
29
273
1.06
0.08
1.2
1.2
—
—
—
0
0
38
362
1.05
0.08
4.4
4.0
23.84
24.84
mmol/l
1.30
33
331
9
87
1.03
0.07
1.1
1.3
602.67
271.61
pmol/l
—
9
75
58
599
0.97
0.06
2.3
2.2
12.07
14.83
nmol/l
1.62
47
524
10
90
1.11
0.05
1.4
1.4
—
—
—
0
0
177
1793
0.98
0.05
5.3
3.8
1.01
1.02
kg/l
1.71
38
280
274
2763
0.99
0.04
2.1
2.2
208.11
271.44
u/l
0.66
257
2566
10
93
1.08
0.02
1.2
1.2
366.52
80.13
mu/l
—
10
85
21
216
0.97
0.00
1.8
1.6
—
—
—
0
0
18
182
0.99
0.00
1.2
1.4
0.45
0.80
nmol/l
2.90
13
151
13
131
0.99
0.00
1.1
1.6
—
—
—
0
0
14
143
0.98
0.00
1.0
1.1
—
—
—
0
0
186
1865
1.00
0.00
3.9
3.5
—
—
—
0
0
6
66
0.91
0.00
2.3
1.2
—
—
—
0
0
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
771
7710
1.00
-0.00
40.3
14.8
34.62
27.03
mg/l
7.80
742
6072
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
6
63
0.95
-0.00
2.5
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
4.72
—
0
5
0
6
0.00
-0.00
0.0
17.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.02
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS – Malignant neoplasm of liver and intrahepatic bile ducts

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).